Physician profile
Heather E Deel
NPI 1861869752
$360.53
in general payments reported to CMS, 2019-2025
9 companies · $20.33 in 2025
The $20.33 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.78 · 2022: $12.25 · 2023: $182 · 2024: $102 · 2025: $20.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $304.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $140.69 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $44.78 | 2022-2024 | Airsupra, Farxiga |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.19 | 2023 | |
| Gilead Sciences, INC. | $37.98 | 2023 | |
| Vanda Pharmaceuticals INC. | $23.16 | 2024 | Fanapt, Hetlioz |
| Alkermes, INC. | $21.14 | 2023 | Vivitrol |
| Lilly USA, LLC | $20.33 | 2025 | Mounjaro, Zepbound |
| Axsome Therapeutics, INC. | $18.75 | 2023 | Auvelity |
| Exact Sciences Corporation | $13.51 | 2024 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Deel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.